Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial

Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - Revision updated to v3.4.3; previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:35:12.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice that warned about potential delays in updates due to government funding; this is an administrative update and does not change the study details.
    Difference
    0.4%
    Check dated 2026-02-11T02:17:21.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding status notice to the page and updated the version from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:08:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    These are minor front-end and metadata updates (glossary toggle, QC-related labels, and version information) with the removal of outdated labels, which do not affect core study content or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:56:19.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T01:29:36.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a new Locations section with California as a site and updated the revision to v3.3.3. Removed the prior California Locations entry and the HHS Vulnerability Disclosure section, replacing the previous revision (v3.3.2) with v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:13:34.000Z thumbnail image

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.